pravastatin has been researched along with Venous Thrombosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, EA; de Craen, AJ; Ford, I; Freeman, DJ; Frölich, M; Gaw, A; Greer, IA; Jukema, JW; Lowe, GD; Robertson, M; Rumley, A; Sattar, N; Slagboom, PE; Stott, DJ; Tobias, ES | 1 |
Doggen, CJ; Heckbert, SR; Lemaitre, RN; Psaty, BM; Smith, NL | 1 |
1 trial(s) available for pravastatin and Venous Thrombosis
Article | Year |
---|---|
Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
Topics: Age Factors; Aged; Aged, 80 and over; Cohort Studies; Double-Blind Method; Female; Follow-Up Studies; Humans; Incidence; Male; Pravastatin; Prospective Studies; Risk Factors; Venous Thrombosis | 2011 |
1 other study(ies) available for pravastatin and Venous Thrombosis
Article | Year |
---|---|
HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women.
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation Factors; Case-Control Studies; Cholesterol; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Postmenopause; Pravastatin; Risk; Simvastatin; Venous Thrombosis | 2004 |